Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
Collaborative computing community role mapping system and method
Method and system for monitoring and treating hemodynamic parameters
Deadline-driven parallel execution of queries
Organic metal complex and its use in organic electroluminescent device
Nucleic acids for cloning and expressing multiprotein complexes
Amplitude-shift-keying (ASK) envelope detector and demodulation circuits
Liquid crystal display panel
  Randomly Featured Patents
Flow detector element of thermosensible flow sensor
Process for producing .alpha.-olefin polymer
Angled mini arm having a clevis assembly
Method for end-to-end hybrid automatic repeat request and system thereof
Single electrode conductivity technique
Shielded blind-mate connector
Solar panel and frame and related methods
Municipal solid waste fuel steam generator with waterwall furnace platens
Apparatus and method for a voltage booster with improved voltage regulator efficiency
Scanning apparatus and method